Druedahl LC, Price WN, Minssen T, Sarpatwari A - JAMA Network Open
- Research Publications
- Regulation and Clinical Evidence
Summary:
Out of more than 100,000 investigational and approved drugs listed in the Pharmaprojects database, developers reported using artificial intelligence (AI) to aid in the development of 164 investigational drugs and 1 approved drug. Thus, the use of AI in drug development has been modest and mostly limited to early-stage applications, such as molecule discovery and screening.
VIEW SOURCE
Recent Work from PORTAL
How Congress Can Fix Expert Advisory Committees
Daval CJR, Kesselheim AS - STAT
- Commentary & Opinion
- Regulation and Clinical Evidence
International Regulatory Status and Reimbursement Recommendations of Haematological Malignancy Drugs Withdrawn from the FDA Accelerated Approval Pathway
Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy
- Research Publications
- Price, Value, and Access
- Regulation and Clinical Evidence
The Impact of Semantics in Medicines Regulation
Costa E, Kesselheim AS - Journal of Law, Medicine, & Ethics
- Commentary & Opinion
- Innovation Incentives and Competition
- Regulation and Clinical Evidence
Program On Regulation, Therapeutics, And Law (PORTAL)
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital • Harvard Medical School
41 Avenue Louis Pasteur, Suite 0B17, Boston, MA 02115
©2026 Program On Regulation, Therapeutics, And Law (PORTAL). All rights reserved.